Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small, dense LDL.
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: The magnitude of the contribution of serum triglycerides to cardiovascular disease risk and the mechanisms by which triglyceride-rich lipoproteins exert their effect on the vascular wall are largely unknown. Postprandial lipemia likewise has been linked to atherosclerosis, but large prospective studies assessing the magnitude of this association are also lacking. Hypertriglyceridemia is characterized by the presence of cholesterol-rich remnant-like lipoproteins and small dense LDL particles, both of which are believed to contribute to cardiovascular disease risk. RECENT FINDINGS: Several large prospective cohort studies and a meta-analysis have been published recently, investigating the association of fasting and nonfasting serum triglycerides with cardiovascular disease. Fasting triglycerides increase the adjusted hazard ratios for cardiovascular disease risk 1.7 x (comparing upper with lower tertile), and nonfasting levels around 2.0 x. Measurement of nonfasting triglycerides may be more feasible and more informative, but standardization of a test meal is necessary. For clinical practice, the concentration of the atherogenic lipoprotein subfractions in hypertriglyceridemia may be reflected best by measuring apolipoprotein B. SUMMARY: Nonfasting triglyceride levels may replace fasting levels in assessing cardiovascular disease risk once standard reference values have been developed. Several atherogenic lipoprotein subfractions can be measured by including apolipoprotein B in addition to HDL, (nonfasting) triglycerides and LDL cholesterol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prospective studies have indicated that, compared with fasting levels, nonfasting serum triglyceride levels may be a better or similar predictor of CVD events in the general population (15-18).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [18]
In the citing paper
“On a general note, given the multiple tests there was the potential for false positive findings; however, if corrected for multiple testing and thus reducing the false positive error rate, the false negative error rate would increase which could lead to missing possible important findings 29.”
From Irregular consumption of energy intake in meals is associated with a higher cardiometabolic risk in adults of a British birth cohort (2014) · cites this paper as [29]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Research works printed but not linked: 1
- de Graaf, 1993, Artery, 20, 201
Cited by
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
Self-citationDekker, M. J., Su, Q., Baker, C., Rutledge, A. C., & Adeli, K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2010 · Cited by 420
D. Kolovou, G., P. Mikhailidis, D., Kovar, J., Lairon, D., G. Nordestgaard, B., Chye Ooi, T., Perez-Martinez, P., Bilianou, H., Anagnostopoulou, K., & Panotopoulos, G. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111795495549 · Cited by 306
Dietary Triacylglycerol Structure and Its Role in Infant Nutrition
Innis, S. M. (2011) · Advances in Nutrition · doi:10.3945/an.111.000448 · Cited by 277
“Most studies on dietary TG structure in adults have focused on postprandial plasma TG clearance, explained in part by the atherogenicity of TG remnants and evidence that elevated TG is an independent risk factor for cardiovascular disease (6,58,59,82,83).”
BackgroundVarbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251
The differential effects of EPA and DHA on cardiovascular risk factors
Cottin, S. C., Sanders, T. A., & Hall, W. L. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000061 · Cited by 247
“Raised fasting and postprandial TAG concentrations are now widely recognised as markers of cardiovascular risk (20,21) .”
Hypertriglyceridemia secondary to obesity and diabetes
Subramanian, S., & Chait, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.003 · Cited by 200
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
Tenenbaum, A., Klempfner, R., & Fisman, E. Z. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-2085133501150912 · Cited by 186
“Prospective studies have indicated that, compared with fasting levels, nonfasting serum TG levels may be a better or similar predictor of CV events in the general population [25-29].”
BackgroundSerum triglycerides and risk of cardiovascular disease
Boullart, A. C. I., Graaf, J. D., & Stalenhoef, A. F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.002 · Cited by 182
Self-citationHealth benefits and phenolic compounds of Moringa oleifera leaves: A comprehensive review
Hassan, M., Xu, T., Tian, Y., Zhong, Y., Ali, F. A. Z., Yang, X., & Lu, B. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153771 · Cited by 181
Gazzaruso, C., Gola, M., Karamouzis, I., Giubbini, R., & Giustina, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2394 · Cited by 151
“In fact, there is recent evidence that small dense LDL (sdLDL) may be independent cardiovascular risk factors (24).”
BackgroundTriglycerides and Cardiovascular Risk
Harchaoui, K., Visser, M., Kastelein, J., Stroes, E., & Dallinga-Thie, G. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788970315 · Cited by 136
“Presence of elevated concentrations of atherogenic TGrich remnant lipoproteins is the principle abnormality responsible for this association [23].”
BackgroundPostprandial lipoproteins and the molecular regulation of vascular homeostasis
Botham, K. M., & Wheeler-Jones, C. P. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.06.001 · Cited by 132
Stanhope, K. L., & Havel, P. J. (2009) · Journal of Nutrition · doi:10.3945/jn.109.106641 · Cited by 144
Lindman, A. S., Veierød, M. B., Tverdal, A., Pedersen, J. I., & Selmer, R. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9501-1 · Cited by 105
“However, it is probably not the nonfasting triglycerides per se that cause atherosclerosis, but rather the cholesterol content of remnant lipoproteins [8, 21].”
BackgroundPot, G. K., Hardy, R., & Stephen, A. M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.51 · Cited by 102
Flaxseed dietary fibers suppress postprandial lipemia and appetite sensation in young men
Kristensen, M., Savorani, F., Christensen, S., Engelsen, S. B., Bügel, S., Toubro, S., Tetens, I., & Astrup, A. V. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.03.004 · Cited by 92
“However, in recent years research has linked elevated postprandial TG concentrations with the development or onset of atherosclerosis and coronary artery disease (CAD) [1,2], proposing that the postprandial concentration may be an independent predictor of CAD.”
BackgroundGodard, M., Décordé, K., Ventura, E., Soteras, G., Baccou, J. C., Cristol, J., & Rouanet, J. (2008) · Food Chemistry · doi:10.1016/j.foodchem.2008.11.084 · Cited by 93
Foley, E. M., Gordts, P. L. S. M., Stanford, K. I., Gonzales, J. C., Lawrence, R., Stoddard, N., & Esko, J. D. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301637 · Cited by 77
Identifying an optimal cutpoint for the diagnosis of hypertriglyceridemia in the nonfasting state
White, K. T., Moorthy, M. V., Akinkuolie, A. O., Demler, O., Ridker, P. M., Cook, N. R., & Mora, S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241752 · Cited by 74
History of Discovery: Platelet-Derived Growth Factor
Bowen‐Pope, D. F., & Raines, E. W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179556 · Cited by 68
Lai, C., Wojczynski, M. K., Parnell, L. D., Hidalgo, B., Irvin, M. R., Aslibekyan, S. W., Province, M. A., Absher, D., Arnett, D. K., & Ordovás, J. M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069948 · Cited by 62
Triglyceride-Rich Lipoproteins and Plasma Lipid Transport
Havel, R. J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178756 · Cited by 57
Pathogenesis and Management of the Dyslipidemia of the Metabolic Syndrome
Raal, F. J. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0079 · Cited by 58
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
Estrada-Luna, D., Ortiz-Rodríguez, M. A., Medina-Briseño, L., Carreón‐Torres, E., Vega, J. A. I., Sharma, A. K., Cancino‐Díaz, J. C., Pérez-Méndez, O. A., Belefant‐Miller, H., & Cabrera, G. B. (2018) · Molecules · doi:10.3390/molecules23112730 · Cited by 54
“endothelial function by decreasing endothelium-dependent vasodilation [153] and increasing the level of adhesion molecules [154].”
BackgroundInactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice
Buchheiser, A., Ebner, A., Burghoff, S., Ding, Z., Romio, M., Viethen, C., Lindecke, A., Köhrer, K., Fischer, J. W., & Schrader, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr218 · Cited by 50
Protective effects of Moringa oleifera Lam. leaves against arsenic–induced toxicity in mice
Sheikh, A., Yeasmin, F., Agarwal, S., Rahman, M., Islam, K., Hossain, E., Hossain, S., Karim, M. R., Nikkon, F., Saud, Z. A., et al. (2014) · Asian Pacific Journal of Tropical Biomedicine · doi:10.12980/apjtb.4.201414b44 · Cited by 49
“Recently, it is reported that BChE activity significantly decreases in human population exposed to arsenic chronically[30].”
BackgroundHepatic Heparan Sulfate Proteoglycans and Endocytic Clearance of Triglyceride-Rich Lipoproteins
Foley, E. M., & Esko, J. D. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93010-x · Cited by 54
Shen, H., Xu, L., Lu, J., Hao, T., Ma, C., Yang, H., Lu, Z., Gu, Y., Zhu, T.-H., & Shen, G. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0143-x · Cited by 47
“Indeed, higher levels of sdLDL particles are considered to be more atherogenic compared with lbLDL cholesterol (lbLDL-C) particles; therefore, sdLDL-C is considered to be an important and independent predictor of cardiovascular diseases (CVD) [4–8].”
Berecochea-Lopez, A., Décordé, K., Ventura, E., Godard, M., Bornet, A., Teissèdre, P., Cristol, J., & Rouanet, J. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803063v · Cited by 42
Pérez‐Martínez, P., Pérez-Caballero, A. I., García‐Ríos, A., Yubero‐Serrano, E. M., Camargo, A., Gómez-Luna, M. J., Marín, C., Gómez-Luna, P., Dembinska-Kiec, A., Rodríguez-Cantalejo, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043390 · Cited by 45
“Several studies have linked the extent of this state to the development of coronary heart disease [1–3].”
BackgroundPot, G. K., Hardy, R., & Stephen, A. M. (2016) · British Journal of Nutrition · doi:10.1017/s0007114515004407 · Cited by 40
Cheung, C. M. G., Gan, A. T. L., Fan, Q., Chee, M. L., Apte, R. S., Khor, C. C., Yeo, I. Y. S., Mathur, R., Cheng, C., Wong, T. Y., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m073684 · Cited by 52
“This is based on studies that have shown that nonfasting lipids are as (if not more) predictive of cardiovascular disease as fasting lipids (67, 68).”
BackgroundMetabolic Syndrome in Hypopituitarism
Miljić, D., & POPOVIC, V. M. (2018) · Frontiers of hormone research · doi:10.1159/000485997 · Cited by 42
Yingchun, H., Ma, Y., Wen, J., He, X., & Xiaohong, Z. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0867-5 · Cited by 36
Cho, Y., Lee, S., Jee, S. H., & Kim, J. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.6.586 · Cited by 37
“An increased number of remnant-like lipoproteins and sdLDL particles were simultaneously present in fasting hypertriglyceridemia or postprandial lipidemia, and in both cases, highly atherogenic [28].”
BackgroundDekker, M. J., Graham, T. E., Ooi, T. C., & Robinson, L. E. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.08.004 · Cited by 32
“Age [31], as well as both fasting and postprandial TAG [32], is an independent risk factor for CVD.”
BackgroundThe influence of major dietary fatty acids on insulin secretion and action
López, S., Bermúdez, B., Abia, R., & Muriana, F. J. G. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346d39 · Cited by 36
Shen, H., Xu, Y., Lu, J., Ma, C., Zhou, Y., Li, Q., Chen, X., Zhu, A., & Shen, G. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0358-8 · Cited by 33
“This is most likely because in large quantities, sdLDL particles are more atherogenic than larger, buoyant LDL-C particles [2, 5].”
BackgroundNutrigenetics of the lipoprotein metabolism
García‐Ríos, A., Pérez‐Martínez, P., Delgado‐Lista, J., López‐Miranda, J., & Pérez‐Jiménez, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100513 · Cited by 33
“Cardiovascular diseases (CVD) continue to be the major causes of morbidity and mortality in developed countries [1, 2] (http://dphpc.ox.ac.uk/bhfprg/stats/2003/).”
BackgroundInfluentialValdivielso, P., Puerta, S., Rioja, J., Alonso, I., Ariza, M. J., Sánchez-Chaparro, M. Á., Palacios, R., & González‐Santos, P. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.12.022 · Cited by 30
Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?
Valdivielso, P., Ramírez-Bollero, J., & Pérez-López, C. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.577 · Cited by 29
Santo, A. S., Santo, A. M., Browne, R. W., Burton, H., Leddy, J. J., Horvath, S. M., & Horvath, P. J. (2010) · Lipids · doi:10.1007/s11745-010-3487-z · Cited by 27
“Three decades later, research has progressively expounded upon this intimation by demonstrating that the postprandial state may be an over-looked, independent risk factor for future cardiac events [5, 8, 22, 26, 35, 36, 52].”
BackgroundTouma, Z., Gladman, D., Ibañez, D., & Urowitz, M. B. (2011) · Rheumatology · doi:10.1093/rheumatology/ker339 · Cited by 27
Linderborg, K. M., Järvinen, R., Lehtonen, H.-M., Viitanen, M. H., & Kallio, H. P. T. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.004 · Cited by 32
Bravo, E., Napolitano, M., & Botham, K. M. (2010) · The Open Translational Medicine Journal · doi:10.2174/1876399501002010001 · Cited by 31
Daytime triglyceride variability in men and women with different levels of triglyceridemia
Klop, B., Cohn, J. S., van Oostrom, A. J. H. H. M., van Wijk, J. P. H., Birnie, E., & Cabezas, M. C. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.08.010 · Cited by 23
“In the future, measurement of non-fasting TG could replace fasting TG once reference values for nonfasting TG have been established [30].”
BackgroundGijbels, A., Erdõs, B., Trouwborst, I., Jardon, K. M. C., Adriaens, M. E., Goossens, G. H., Blaak, E. E., Feskens, E. J. M., & Afman, L. A. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02188-0 · Cited by 26
Rotundic acid alleviates hyperlipidemia in rats by regulating lipid metabolism and gut microbiota
Zeng, W., Yang, B. H., Wang, Y., Sun, M., Yang, W.-Q., Cui, H., Jin, J., & Zhao, Z. (2023) · Phytotherapy Research · doi:10.1002/ptr.8008 · Cited by 21
“However, metabolic disturbances in the synthesis of TAGs in the liver and plasma have been identified as risk factors for cardiovascular-related diseases (Stalenhoef & de Graaf, 2008).”
BackgroundRysz-Górzyńska, M., Gluba-Brzózka, A., & Banach, M. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666161003093032 · Cited by 20
Lee, S. H., Lee, B., Won, H. K., Moon, J. H., Kim, K. J., Kang, E. S., Soo, B., & Lee, H. C. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.4.404 · Cited by 20
“Accordingly, postprandial or non-fasting TG levels are increasingly used as a predictor for CVD [13].”
InfluentialNutrient gene interactions in lipid metabolism
Minihane, A. M. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832c94a5 · Cited by 20
Grosskopf, I., Shaish, A., Afek, A. B., Shemesh, S., Harats, D., & Kamari, Y. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.04.011 · Cited by 22
“In the past decades it has become increasingly appreciated that the metabolic fate of triglyceride-rich lipoproteins (TRL), rather than the level of plasma triglyceride in and of itself, carries the potential to modify the susceptibility to early development of atherosclerosis [1,2].”
BackgroundClinical Considerations and Mechanistic Determinants of Postprandial Lipemia in Older Adults
Katsanos, C. S. (2014) · Advances in Nutrition · doi:10.3945/an.113.004903 · Cited by 23
“The idea of developing a standardized fat-tolerance test in parallel with the establishment of relevant reference values of clinical importance (69,70) to predict CVD risk is not different from the well-established application of the glucose tolerance test to predict the risk of type 2 diabetes.”
BackgroundVázquez, N. M., Redondo‐Rodríguez, R., Rioja, J., Jiménez-Núñez, F. G., Arija, S. M., Lisbona-Montañez, J. M., Cano‐García, L., Rojas-Gimenez, M., Garnica, I. U., Valdivielso, P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10010133 · Cited by 19
“This triglyceride intolerance syndrome results from difficulty processing triglyceride-rich lipoproteins, which in turn increase the risk of atherosclerosis [10,11].”
BackgroundPetersen, K. S., Rogers, C. J., West, S. G., Proctor, D. N., & Kris‐Etherton, P. M. (2020) · Food & Function · doi:10.1039/c9fo02438g · Cited by 18
Beals, E., Kamita, S. G., Sacchi, R., Demmer, E., Rivera, N., Rogers-Soeder, T. S., Gertz, E., Loan, M. D. V., German, J. B., Hammock, B. D., et al. (2019) · Journal of Nutritional Science · doi:10.1017/jns.2019.11 · Cited by 18
“The addition of MFGM to a high-SFA dairy product-based meal resulted in a significant decrease in insulin response and attenuation of lymphocyte soluble epoxide hydrolase (sEH) expression.”
BackgroundInfluentialFenofibrate Reduces Postprandial Hypertriglyceridemia in CD36 Knockout Mice
Sandoval, J. C., Nakagawa-Toyama, Y., Masuda, D., Tochino, Y., Nakaoka, H., Kawase, R., Yuasa‐Kawase, M., Nakatani, K., Inagaki, M., Tsubakio‐Yamamoto, K., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3988 · Cited by 18
Biological mechanisms underlying widowhood's health consequences: Does diet play a role?
Fagundes, C. P., & Wu‐Chung, E. L. (2021) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2021.100058 · Cited by 16
Goff, L. M., Whyte, M., Samuel, M., & Harding, S. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0315-3 · Cited by 16
“Post-prandial lipid handling has not been previously investigated in this ethnic group despite the growing body of evidence to show their importance as indicators of a proatherogenic state [34, 35].”
BackgroundFasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes
Mancera‐Romero, J., Sánchez-Chaparro, M. Á., Rioja, J., Ariza, M. J., Olivecrona, G., González‐Santos, P., & Valdivielso, P. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0434-x · Cited by 15
“Epidemiologic studies have shown that non-fasting levels of triglycerides are more closely associated with vascular disease than fasting triglycerides [4].”
BackgroundTriglyceride Treatment in the Age of Cholesterol Reduction
Agrawal, N., Corradi, P. F., Gumaste, N., & Goldberg, I. J. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.08.003 · Cited by 15
Foo, V. H. X., Yanagi, Y., Nguyen, Q. D., Sabanayagam, C., Lim, S. H., Neelam, K., Wang, J. J., Mitchell, P. L. R., Cheng, C., Wong, T. Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27202-w · Cited by 16
Minich, D. M., Lerman, R. H., Darland, G. K., Babish, J. G., Pacioretty, L. M., Bland, J. S., & Tripp, M. L. (2010) · Journal of Nutrition and Metabolism · doi:10.1155/2010/467316 · Cited by 14
“7 times increased risk for cardiovascular disease [26].”
BackgroundDing, C., Hsu, S. H.-J., Wu, Y., & Su, T. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-179 · Cited by 13
“Abbreviations CVD: Cardiovascular disease; CHD: Coronary heart disease; LDL: Low-density lipoprotein; LDL-C: Low-density lipoprotein cholesterol; FPG: Fasting plasma glucose; OGTT: Oral glucose tolerance test; HbA1c: Glycated hemoglobin; GluAUC: Glucose area under curve; HDL-C: High-density lipoprotein cholesterol; sd…”
BackgroundInfluentialKen-ichi, S. A. T. O., Seimiya, M., Kodera, Y., Kitamura, A., & Nomura, F. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.11.026 · Cited by 13
“Growingevidence, however, suggests that hypertriglyceridemia is also a risk factor for cardiovascular disease [20].”
BackgroundYui, K., Imataka, G., & Shiohama, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914796 · Cited by 12
“Non-fasting triglyceride levels may replace fasting levels when evaluating cardiovascular disease risk [82].”
BackgroundHe, W., Mori, M., Yu, X., & Kanda, T. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-015-0168-1 · Cited by 12
“Individuals with hyperglyceridemia are prone to produce strongly atherogenic lipoproteins, such as cholesterol-rich remnant-like lipoproteins and small dense LDL particles [43].”
BackgroundVázquez, N. M., Rojas-Gimenez, M., Jiménez-Núñez, F. G., Arija, S. M., Rioja, J., Ruiz‐Limón, P., Garnica, I. U., Cabezas, M. C., Valdivielso, P., & Fernández‐Nebro, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082483 · Cited by 13
“Intolerance to triglycerides arises from the inability to process triglyceride-loaded lipoproteins, which in turn increases the risk of atherosclerosis [18,19].”
BackgroundWho would benefit most from postprandial lipid screening?
Sciarrillo, C. M., Koemel, N. A., Keirns, B. H., Banks, N. F., Rogers, E. M., Rosenkranz, S. K., Kurti, S. P., Jenkins, N. D. M., & Emerson, S. R. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.04.022 · Cited by 13
Branchi, A., Torri, A., Berra, C., Colombo, E., & Sommariva, D. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/215052 · Cited by 12
“Hindawi Publishing Corporation Journal of Nutrition and Metabolism Volume 2012, Article ID 215052, 8 pages doi:10.1155/2012/215052”
BackgroundInfluentialLiu, S., Wang, D., Li, B., Li, K., Dai, X., Cheng, L., Wang, J., Huang, T. C., Tang, Y., & Xiao, Y. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522002975 · Cited by 11
“Elevated TAG-rich remnant lipoproteins promoted responsible for atherosclerosis formation (46) .”
Nagatomo, A., Kohno, M., Kawakami, H., Manse, Y., & Morikawa, T. (2023) · Journal of Natural Medicines · doi:10.1007/s11418-023-01756-0 · Cited by 11
“Therefore, it has been reported that the number of sdLDL particles is a more accurate prediction of ASCVD risk than LDL-C [3, 8–10].”
BackgroundPlatelet function in the postprandial period
Sinzinger, H. F., & Berent, R. (2012) · Thrombosis Journal · doi:10.1186/1477-9560-10-19 · Cited by 9
“HTG has been associated with cardiovascular disease since the early 70ies [44].”
BackgroundYamashita, M., Iwata, A., Kato, Y., Futami, M., Imaizumi, S., Kuwano, T., Ike, A., Sugihara, M., Nishikawa, H., Zhang, B., et al. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1173-x · Cited by 8
Gijbels, A., Jardon, K. M. C., Trouwborst, I., Manusama, K., Goossens, G. H., Blaak, E. E., Feskens, E. J. M., & Afman, L. A. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.05.027 · Cited by 7
Triglyceride enhances susceptibility to TNF-α-induced cell death in THP-1 cells
Lim, J., Kim, Y. S., Kim, S. H., Cho, Y., Lee, M. H., Jung, B. C., Jung, D., & Rhee, K.-J. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0144-y · Cited by 8
“To determine if TG could induce differentiation of THP-1 monocytes into THP-1 macro- phages, we examined the mRNA expression levels of the macrophage-specific markers, CD11b, CD18, CD36 and CD68, by RT-PCR analysis.”
Kolovou, G. D., Anagnostopoulou, K. K., & Mikhailidis, D. P. (2009) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192400903010048 · Cited by 7
“The understanding of postprandial lipemia is important, since postprandial hypertriglyceridemia is involved in endothelial dysfunction, oxidative stress, small dense LDL and small dense HDL particles [45].”
BackgroundFeng, F., Zhong, Y.-X., Yang, C., Lin, F., Huang, J.-H., Mai, Y., Zhao, P., Wei, W., Zhu, H.-C., & Xu, Z. (2023) · BMC Urology · doi:10.1186/s12894-023-01291-w · Cited by 7
Güven, C., Pala, A. A., & Urcun, Y. S. (2021) · The Journal of Vascular Access · doi:10.1177/11297298211011864 · Cited by 5
Anding, R. H. (2009) · Medical Entomology and Zoology · Cited by 7
Diabetic Dyslipidemia - Role of Saroglitazar
Majumder, A. (2014) · Medicinal Chemistry · doi:10.4172/2161-0444.1000212 · Cited by 7
Saarinen, H. J., Husgafvel, S., Pohjantähti‐Maaroos, H., Wallenius, M., & Palomäki, A. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0340-7 · Cited by 5
Fan, W., Philip, S., Toth, P. P., Granowitz, C. B., & Wong, N. D. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100087 · Cited by 4
“One possible argument is that the predominant TG lipoproteins are chylomicrons in patients with severe hypertriglyceridemia, which are too large to penetrate the endothelial surface and promote atherosclerosis [8].”
BackgroundStudy, T. D. C. O. A. E. O. A.-H. D. (. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir329 · Cited by 4
Association between Lp(a) and small dense LDL in menopausal women without metabolic syndrome
Gentile, M., Iannuzzo, G., Mattiello, A., Marotta, G., Rubba, F., Iannuzzi, A., Panico, S., & Rubba, P. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1481599 · Cited by 4
“It is generally held that hypertriglyceridaemia leads to enhanced production of relatively smaller LDL with shift in diameters distribution of all LDL particles [18].”
BackgroundAndo, H., Kurita, S., Shimizu, A., Kato, K., Ishikura, K., Taji, K. N., Uno, M., Takeshita, Y., Misu, H., Fujimura, A., et al. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05708.x · Cited by 3
“lipoproteins, the levels of which are increased in hypertriglyceridaemia, are thought to be atherogenic factors.(34) It has been demonstrated that both insulin aspart(35) and insulin lispro(36) have more”
BackgroundPark, S.-Y., Park, T. G., Choi, K., Kim, K. J., & Kim, J. Y. (2024) · Nutrients · doi:10.3390/nu16172864 · Cited by 3
“An increase in postprandial TG is directly associated with reduced VLDL cholesterol, while other lipoproteins reportedly possess the ability to activate platelets [22,23].”
BackgroundRole of Lipoproteins in Carotid Arterial Disease
Avgerinos, E. D., & Liapis, C. D. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4429-8_4 · Cited by 2
Lee, D. H., Kim, Y. S., Lim, J., Cho, Y., Jung, B. C., Pan, C., Kim, H.-K., & Rhee, K. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0105-5 · Cited by 2
“Using a variety of chemical inhibitors for cell signaling pathways we demonstrate that TG-induced down-regulation of MMP-12 occurs in part by activation of the NF-jB pathway.”
BackgroundPerotti, M., Caumo, A., Brunani, A., Cambiaghi, N., Casati, M., Scacchi, M., Perra, S., Rocco, C., Mancia, G., Grassi, G. M., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04416.x · Cited by 3
Gupta, L. K. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i5.10 · Cited by 2
Rezaei, M., Palizban, A., Zamani-Doabi, S., & Shojaee, M. (2016) · Journal of Biology and Today s World · doi:10.15412/j.jbtw.01050703 · Cited by 2
Alouffi, S. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/12777 · Cited by 2
Evaluation of serum adiponectin and lipid profile in patients with acne vulgaris
Alashry, S. E., Sallam, M., Hassan, M. A., & Elhennawy, E. S. (2023) · Egyptian Journal of Dermatology and Venerology · doi:10.4103/ejdv.ejdv_6_23 · Cited by 1
The Model for Evaluation on Blood Flow of Functional Food in Human Intervention Study
Lim, Y., Kwon, O., & Kim, J. Y. (2018) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2018.7.2.88 · Cited by 1
Experimental and computational studies on lipoprotein lipolysis at acidic pH
Lähdesmäki, K. (2010) · Helda - University of Helsinki Institutional Repository · Cited by 1
Targeting Apolipoproteins in Magnetic Resonance Imaging
Sriram, R., Lagerstedt, J. O., Samardzic, H., Kreutzer, U., Petrolova, J., Xie, H., Kaysen, G. A., Voss, J. C., Desreux, J. F., & Jue, T. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-314-5_12
“Cholesterol intake should not exceed 300 mg/day [6, 7 ].”
BackgroundRelação da lipemia pós prandial com aterosclerose avaliada pela angiotomografia coronária
Staniak, H. L. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-04042014-095144
Metadata
- Authors
- Stalenhoef, A. F., & de Graaf, J.
- Affiliations
- Radboud University Medical Center (NL)
- Corresponding author
- Stalenhoef, Anton FH
- Venue
- Current Opinion in Lipidology
- Published
- 2008-08
- Volume
- 19
- Issue
- 4
- Pages
- 355-361
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2007948928
- Cited by
- 121
- References
- 54
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 10 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 8 · 2017: 1 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 9
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- serum triglycerides, fasting triglycerides, cardiovascular risk, small dense LDL, hypertriglyceridemia, postprandial lipemia, apolipoprotein B, atherosclerosis
- MeSH terms
- Cardiovascular Diseases, Fasting, Humans, Cholesterol, LDL, Risk Factors, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.